Furthermore, platelet activation in APS was accompanied by upregulation of the mTORC2/Akt pathway and enhanced phosphorylation of SIN1 at threonine, and patient-derived aβ2GPI antibodies were shown to enhance platelet activation via this pathway (24). Here, MAPKAP1 is linked to autoimmune polyendocrinopathy.